1 / 11

Industry Exposure Trends and Voluntary Blood Lead Reduction Programs European Lead Industry

This report examines the voluntary blood lead reduction programs implemented by the European lead industry to manage lead exposure in the workplace. The collected blood lead data demonstrates that the industry is continually improving in risk management and shows compliance with REACH regulations. Companies are encouraged to continue reducing blood lead levels of employees.

atkinsonr
Download Presentation

Industry Exposure Trends and Voluntary Blood Lead Reduction Programs European Lead Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Industry Exposure Trends and Voluntary Blood Lead Reduction Programs European Lead Industry Aggie Kotze REACH Manager International Lead Association - Europe

  2. ILA-Europe Blood Pb collectionBackground • Blood lead data has been collected for the purposes of the: • Voluntary risk assessment (1998-2001) • REACH (2008-2010, updated 2013) • Data collected from manufacturers but also Downstream users sectors • For REACH purposes • Companies provided individualworker (not aggregated or averaged) blood lead data via a questionnaire • Data collected on anonymous basis • Statistical analysis undertaken by ILA

  3. ILA-Europe Blood Pb collectionBackground • Purpose of blood lead data collection exercise • To show European authorities that industry is continually improving in managing lead exposure in the workplace by adopting effective risk management measures • To demonstrate for each use that the 90thpercentile of exposure data is below the DNEL of 40 µg/dLand thus demonstrate risk is controlled Derived no-effect level (DNEL): is the level of exposure to a substance above which humans should not be exposed.

  4. 2010 REACH registration dossier - reported distributions for blood lead data at the 75th percentile to demonstrate exposures BELOW the DNEL for the period 2005-2007. 2013 REACH registration dossier update - blood lead data reported for companies adopting agreed RMM at the 90th percentile for the exposure period 2009-2012 (requested by ECHA) ILA-Europe Blood Pb collectionBackground 90th percentile – considered worst case of exposure under REACH

  5. REACH blood lead data (90th percentile) Blood lead (µg/dL) Blood lead (µg/dL) Year

  6. Sector Blood Lead Data

  7. Primary Lead Producers Data for 8 legal entities (2009-2012)

  8. Secondary Lead Producers

  9. Lead Oxide & Stabiliser Producers

  10. Lead Sheet Producers

  11. Key messages • Good response from companies on blood lead data collection • Robust and representative dataset available for all EU sectors • Data demonstrates adequate control for all sectors if Companies adopt risk management measures specified in REACH Chemical Safety Reports (RCR <1) • Sector REACH compliance is however dependant on performance of individual companies as assessed against worst 10% of data • Companies are encouraged to continuously reduce blood lead levels of employees

More Related